We are live on
!
Find out more
SGK
Steigerwald Gordon & Koch Portfolio holdings
AUM
$1.01B
Turnover
3.56%
1-Year Est. Return
15.33%
This Fund
S&P 500
This Quarter
Est. Return
+8.38%
1 Year Est. Return
+15.33%
3 Year Est. Return
+59.48%
5 Year Est. Return
+77.26%
10 Year Est. Return
+288.1%
AUM
$1.01B
AUM Growth
+$34.7M
(+3.6%)
Cap. Flow
-$17.9M
Cap. Flow
% of AUM
-1.78%
Top 10 Holdings %
Top 10 Hldgs %
33.86%
Holding
786
New
7
Increased
79
Reduced
120
Closed
21
Avg Time Held
1.7
years
Top 10 Avg Time Held
2.5
years
Top 20 Avg Time Held
4.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$9.81M |
| 2 |
Cadence Design Systems
CDNS
|
+$8.36M |
| 3 |
Qnity Electronics Inc
Q
|
+$495K |
| 4 |
Stryker
SYK
|
+$201K |
| 5 |
DuPont de Nemours
DD
|
+$149K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T. Rowe Price
TROW
|
+$4.26M |
| 2 |
Adobe
ADBE
|
+$3.9M |
| 3 |
Zoetis
ZTS
|
+$3.65M |
| 4 |
ExxonMobil
XOM
|
+$3.22M |
| 5 |
General Mills
GIS
|
+$2.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.78% |
| 2 | Healthcare | 15.82% |
| 3 | Financials | 14.92% |
| 4 | Industrials | 12.14% |
| 5 | Consumer Staples | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
626
Liberty Live Group Series C
LLYVK
$9.17B
| $4.33K | ﹤0.01% |
41
| – | – |
2025 Q3
3 quarters
|
|
627
Charles River Laboratories
CRL
$14.6B
| $4.31K | ﹤0.01% |
19
| – | – |
2025 Q3
3 quarters
|
|
628
APA Corp
APA
$16.5B
| $4.29K | ﹤0.01% |
132
+1
| +0.8% | +$38 |
2025 Q3
3 quarters
|
|
629
Global X Social Media ETF
SOCL
$86.9M
| $4.29K | ﹤0.01% |
98
| – | – |
2025 Q3
3 quarters
|
|
630
Infosys
INFY
$49.1B
| $4.28K | ﹤0.01% |
408
| – | – |
2025 Q3
3 quarters
|
|
631
Leidos
LDOS
$15.6B
| $4.22K | ﹤0.01% |
41
| – | – |
2025 Q3
3 quarters
|
|
632
Strategy Inc
MSTR
$64.1B
| $4.17K | ﹤0.01% |
48
-557
| -92% | -$80.9K |
2025 Q3
3 quarters
|
|
633
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.94B
| $4.16K | ﹤0.01% |
60
| – | – |
2025 Q3
3 quarters
|
|
634
Elanco Animal Health
ELAN
$11.8B
| $4.11K | ﹤0.01% |
167
-550
| -77% | -$12.7K |
2025 Q3
3 quarters
|
|
635
T. Rowe Price Capital Appreciation Equity ETF
TCAF
$9.1B
| $4.11K | ﹤0.01% |
100
| – | – |
2025 Q3
3 quarters
|
|
636
Huntington Bancshares
HBAN
$31B
| $4.08K | ﹤0.01% |
230
| – | – |
2025 Q3
3 quarters
|
|
637
Cooper Companies
COO
$10.9B
| $3.94K | ﹤0.01% |
55
| – | – |
2025 Q4
2 quarters
|
|
638
AdvisorShares Pure Cannabis ETF
YOLO
$30.3M
| $3.94K | ﹤0.01% |
1,364
| – | – |
2025 Q3
3 quarters
|
|
639
Watts Water Technologies
WTS
$11.9B
| $3.92K | ﹤0.01% |
10
| – | – |
2025 Q3
3 quarters
|
|
640
Viatris
VTRS
$20.9B
| $3.86K | ﹤0.01% |
243
+15
| +7% | +$232 |
2025 Q3
3 quarters
|
|
641
Stifel
SF
$10.4B
| $3.84K | ﹤0.01% |
55
| – | – |
2025 Q3
3 quarters
|
|
642
WESCO International
WCC
$16.9B
| $3.8K | ﹤0.01% |
11
| – | – |
2025 Q3
3 quarters
|
|
643
iShares China Large-Cap ETF
FXI
$3.94B
| $3.73K | ﹤0.01% |
118
+1
| +0.9% | +$36 |
2025 Q3
3 quarters
|
|
644
International Flavors & Fragrances
IFF
$23B
| $3.72K | ﹤0.01% |
47
| – | – |
2025 Q3
3 quarters
|
|
645
Rollins
ROL
$16.3B
| $3.67K | ﹤0.01% |
88
| – | – |
2025 Q4
2 quarters
|
|
646
Toronto Dominion Bank
TD
$196B
| $3.64K | ﹤0.01% |
30
| – | – |
2025 Q3
3 quarters
|
|
647
Houlihan Lokey
HLI
$8.98B
| $3.49K | ﹤0.01% |
26
| – | – |
2025 Q3
3 quarters
|
|
648
First Trust Cloud Computing ETF
SKYY
$3.38B
| $3.48K | ﹤0.01% |
26
| – | – |
2025 Q3
3 quarters
|
|
649
Zebra Technologies
ZBRA
$17.9B
| $3.42K | ﹤0.01% |
13
| – | – |
2025 Q4
2 quarters
|
|
650
Huntington Ingalls Industries
HII
$10.5B
| $3.36K | ﹤0.01% |
12
| – | – |
2025 Q3
3 quarters
|
|
Similar funds
RIM
KCL
CFP
IWP
OAM
GCM
DPW
QFA
Steigerwald Gordon & Koch's Q2 2026 Portfolio in Review
As of Q2 2026, Steigerwald Gordon & Koch held 786 positions worth $1.01B, up 3.6% from $974M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 3.6%. Steigerwald Gordon & Koch opened 7 new positions and exited 21, leaving the 786-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Steigerwald Gordon & Koch's largest Q2 2026 buy was Honeywell Aerospace: 219 shares worth $48.4K.
- Steigerwald Gordon & Koch added most to Goldman Sachs in Q2 2026, an estimated $9.81M increase.
- Steigerwald Gordon & Koch's biggest Q2 2026 reduction was T. Rowe Price, cutting an estimated $4.26M.
- Steigerwald Gordon & Koch fully exited ExxonMobil in Q2 2026, selling an estimated $3.22M.
- Steigerwald Gordon & Koch's ten largest holdings make up 34% of its $1.01B portfolio in Q2 2026.
- Steigerwald Gordon & Koch opened 7 new positions and closed 21 in Q2 2026.
- Steigerwald Gordon & Koch's portfolio value rose 3.6% quarter-over-quarter to $1.01B.
Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.